Logo Logo
Help
Contact
Switch Language to German

Ricotti, Rosalinda; Ciardo, Delia; Fattori, Giovanni; Leonardi, Maria Cristina; Morra, Anna; Dicuonzo, Samantha; Rojas, Damaris; Pansini, Floriana; Cambria, Raffaella; Cattani, Federica; Gianoli, Chiara; Spinelli, Chiara; Riboldi, Marco; Baroni, Guido; Orecchia, Roberto and Jereczek-Fossa, Barbara Alicja (2017): Intra-fraction respiratory motion and baseline drift during breast Helical Tomotherapy. In: Radiotherapy and Oncology, Vol. 122, No. 1: pp. 79-86

Full text not available from 'Open Access LMU'.

Abstract

Background and purpose: To investigate the intra-fraction breast motion during long-lasting treatments of breast cancer with Helical Tomotherapy by means of an optical tracking system. Materials and methods: A set of seven radio-transparent passive markers was placed on the thoracoabdominal surface of twenty breast cancer patients and tracked by an infrared tracking system. A continuous non-invasive monitoring of intra-fraction motion from patient setup verification and correction to the end of radiation delivery was thus obtained. The measured displacements were analysed in terms of cyclic respiratory motion and slow baseline drift. Results: The average monitoring time per patient was 15.57 min. The breathing amplitude of the chest was less than 2 mm, on average, along all anatomical directions. The baseline drift of the body led to more significant setup uncertainties than the respiratory motion. The main intra-fraction baseline drifts were in posterior and inferior directions and occurred within the first eight minutes of monitoring. Considering the intra-fraction motion only, the resultant clinical-to-planning target volume safety margins are highly patient-specific and largely anisotropic. Conclusion: The non-respiratory motion occurring during prolonged treatments induces notable uncertainties. Non-invasive continuous monitoring of patient setup variations including baseline drifts is recommended in order to minimize dosimetric deviations, which might jeopardize the therapeutic ratio between target coverage and the sparing of organs at risk.

Actions (login required)

View Item View Item